Alembic’s Generic of Allergan’s Rapaflo Approved for Hyperplasia

Alembic Pharmaceuticals received the FDA’s approval for its Silodosin capsules (4mg and 8mg) as a generic to Allergan’s Rapaflo (silodosin).

Silodosin is a selective alpha 1 adrenergic receptor antagonist indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia.

The company now has a total of 108 ANDA approvals, including 96 final approvals and 12 tentative approvals.